The effect of triethanolamine application on anthralin-induced inflammation and therapeutic effect in psoriasis.
prospective_cohort · Level II
Where this comes from
- Record sourced from PubMed, PMID 2142172.
- No licence information is recorded for this record.
- Because redistribution is not established, this page shows the abstract only. Follow the links below for the full text.
Abstract
Twenty patients with chronic plaque psoriasis were treated with short-contact anthralin followed by 10% triethanolamine application to one side of the body and aqueous cream to the other. Anthralin-induced inflammation was inhibited on the triethanolamine-treated side whereas anthralin therapy had to be temporarily stopped in 18 patients on the aqueous cream side because of anthralin-induced inflammation. Therapeutic response was not different in the two sides. This study shows that anthralin-induced inflammation and its therapeutic effect can be dissociated.
Medical subject headings
- Anthralin
- Drug Eruptions
- Ethanolamines
- Psoriasis